Yale School of Medicine (YSM) researchers have tested a new and potentially more sensitive neuroimaging tool for diagnosing behavioral variant frontotemporal dementia (bvFTD). They reported their findings on April 9 in the ...
Apr 16, 2026
0
4
While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in the brain, they have struggled to understand how these harmful fragments are produced. Now, in a ...
Feb 11, 2026
2
131
A multi-institute team led by St. Jude Children's Research Hospital and UT Southwestern Medical Center investigators established for the first time how certain drugs used to treat epilepsy affect their target.
Dec 2, 2025
0
14
Progressive supranuclear palsy (PSP) is a severe and rapidly progressing neurodegenerative disease that affects both motor and cognitive functions. Often misdiagnosed or underdiagnosed due to a lack of specific biomarkers, ...
Dec 16, 2024
0
23
The first-line pharmacological treatment for major depressive disorder (MDD) are antidepressant drugs known as selective serotonin re-uptake inhibitors (SSRIs). But a significant proportion of people don't respond to these ...
Oct 24, 2023
0
34
SSRI antidepressants normally take a few weeks before any showing mental health benefits, but how come it takes so long? Now a study from a group of clinicians and scientists provides the first human evidence that this is ...
Oct 9, 2023
0
56
